Ezetimibe Market Gains Traction with Rising Focus on Cholesterol Management and Cardiovascular Health https://dataintelo.com/report/ezetimibe-market-report The Ezetimibe Market is gaining significant momentum globally, driven by increasing awareness of cholesterol-related health conditions and the growing demand for effective lipid-lowering medications. Ezetimibe, a cholesterol absorption inhibitor, is widely used to treat hyperlipidemia and reduce the risk of cardiovascular diseases, making it a crucial component of modern cardiovascular care protocols. As of 2024, the global Ezetimibe Market is valued at USD 1.67 billion and is projected to grow to USD 2.96 billion by 2032, expanding at a CAGR of 7.2% during the forecast period. This growth is largely fueled by an aging population, unhealthy lifestyle trends, and the increasing prevalence of heart disease and stroke worldwide.